Silvie Hojna

Institute of Physiology of the Czech Academy of Sciences

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Michal Behuliak

Institute of Physiology of the Czech Academy of Sciences

CZECH REPUBLIC

View details

Irena Markova

Institute of Experimental Medicine

CZECH REPUBLIC

View details

Hana Malinska

Institute of Experimental Medicine

CZECH REPUBLIC

View details

Ivana Vaneckova

Head, Researcher

Institute of Physiology of the Czech Academy of Sciences

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Silvie Hojna

Research Interests

Contact this professor

Articles (7)

Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein.

Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.

Both central sympathoexcitation and peripheral angiotensin II-dependent vasoconstriction contribute to hypertension development in immature heterozygous Ren-2 transgenic rats.

Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension.

Effects of systemic and renal intramedullary endothelin-1 receptor blockade on tissue NO and intrarenal hemodynamics in normotensive and hypertensive rats.

Contribution of selected vasoactive systems to blood pressure regulation in two models of chronic kidney disease.

Sex differences in blood pressure of aged Ren-2 transgenic rats.

Collaborators (4)

Michal Behuliak

Irena Markova

Hana Malinska

Ivana Vaneckova

Make your next move.